Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

Capacity demands for biologic-based drugs are shifting due to high-volume demands for blockbuster and biosimilar drugs, and smaller-volume demands of targeted therapies. How is the industry responding to production-related challenges?

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

The session will be held on the show floor at the Innovation Stage and is open to all show attendees.

10:30–11 am
State of the Bioprocessing Industry: Global Shifts in Capacity, Innovations, and Trends in Outsourcing
Learn about research findings and trends in capacity demands and the application of bioprocessing technologies gleaned from a comprehensive survey of industry practices and perceptions. The discussion will include the role contract manufacturing organizations in meeting the production needs of biopharma companies.
Speaker: Eric Langer, president and managing partner, BioPlan Associates Learn more

11 am–noon
Solutions for Efficient, Cost-Effective Biologic Drug Manufacturing
Following lengthy research and development phases, drug companies are incentivized to get drugs to market quickly and seek efficient, cost-effective ways to expedite drug manufacturing processes. Equipment and facility manufacturers are introducing technology advances and contract manufacturers are offering alternatives to inhouse manufacturing. A panel of bioprocessing experts will discuss and debate how technologies and innovative manufacturing strategies can be implemented to advance the efficiency and cost-effectiveness of biomanufacturing processes. Topics include expedited process development, single-use systems, flexible facilities, scale out of multiplexed single-use bioreactors, biopharma/contract manufacturing arrangements, and more.
Panelists:
Eric Langer, president and managing partner, BioPlan Associates
Brady Cole, vice-president, applications, ABEC
Madhu Raghunathan, product strategy leader for BioProcess Hardware, GE Healthcare
Mike Felo, director, downstream process integration, next generation processing, MilliporeSigma
Steve Perry, senior director, manufacturing sciences, Catalent Biologics
Rick Morris, senior vice-president, research and development, Pall Biotech
Rita Peters, editorial director, BioPharm International and Pharmaceutical TechnologyLearn more

Click here to see more Keynote series information.

Click here and use promo code IPXREG to register for INTERPHEX.